登录

Rishena Raises Tens of Million Yuan Series A financing

作者: Mailman 2019-10-27 22:43
瑞神安医疗
http://www.rishena.com/
企业数据由 动脉橙 提供支持
植入式医疗器械研发生产商 | C轮 | 运营中
中国-江苏
2023-05-10
比邻星创投
查看

According to 36Kr.com, Rishena has completed its Series A financing of tens of million yuan, which is jointly invested by Apon Medical and Rays Venture Capital. Proceeds from the financing will mainly be used for clinical trials, product development, and marketing of the implantable spinal cord stimulator.


Rishena originated from the research project of the new implantable gastric electric stimulator launched by the institute of microelectronics of Tsinghua University and China-Japan Friendship Hospital in 2009. The team has started to develop an implantable neural stimulator. After more than 3 years of practice, the team developed a commercialized prototype of the gastric electric stimulator and vagus nerve stimulator.


In 2013, Rishena was registered in Changzhou, Jiangsu, and completed the development of an implantable gastric electric stimulator and implantable vagus nerve stimulator. In 2015, it carried out clinical trials of the implantable vagus nerve stimulator. At present, this product has passed the clinical test, waiting for the approval of the Food and Drug Administration, and is expected to be on sale this year.


Vagus Nerve Stimulation (VNS) is mainly aimed at the treatment of intractable epilepsy which cannot be solved by drug therapy or excision. The effective rate of VNS for patients with intractable epilepsy is more than 50% (at least reduce the number of attacks by 50%), among which nearly 10% of patients are not attacked at all.


The VNS products of Rishena have a few innovations on the basis of the existing products on the market, including adjusting craft, more comfortable treatment, and better performance. The products can also be controlled remotely so that the patient can avoid remote visits and accept the treatment at home.


>>>>

About Apon Medical


Founded in 2001, Jiangsu Apon Medical Technology Co., LTD. (Apon Medical) has been actively engaged in making medical health services more comfort in China. The company is striving to become a public device and system integration manufacturer based on mobile Internet technology in the field of pain management and nasal care.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

流动性退潮倒计时?生物科技企业冲刺IPO

【首发】康沣生物完成数亿元B轮融资,浩悦资本担任独家财务顾问

Coronary Medical Devices Company HS Medical Raises ¥40M in Series Pre-A Round

Tisenc Medical Closes on ¥80M Series B Financing

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

医疗创新大势下的投资逻辑及新型孵化器模式,生命资本和强生创新JLABS这样解读

2019-10-27
下一篇

Baikemy Completes Tens of Million Dollars Series B Financing

2019-10-27